First-Ever Four-Year MIGS Pivotal Trial Results Show Hydrus Microstent Significantly Reduces Need for Invasive Surgery and Subsequent Glaucoma Medication
February 27, 2020 06:00 ET
|
Ivantis Inc.
IRVINE, Calif., Feb. 27, 2020 (GLOBE NEWSWIRE) -- Ivantis, Inc., developer of the novel Hydrus® Microstent, a minimally invasive glaucoma surgery (MIGS) device designed to lower eye pressure for...
Ivantis Announces Results of Hydrus(TM) Intracanalicular Implant Study
September 16, 2011 12:26 ET
|
Ivantis, Inc.
IRVINE, Calif., Sept. 16, 2011 (GLOBE NEWSWIRE) -- Ivantis, a developer of novel intraocular devices designed to treat glaucoma by lowering the intraocular pressure (IOP) in the eye, announced today...